ECM Modifications Driven by Age and Metabolic Stress Directly Promote Vascular Smooth Muscle Cell Osteogenic Processes

Arterioscler Thromb Vasc Biol. 2025 Mar;45(3):424-442. doi: 10.1161/ATVBAHA.124.321467. Epub 2025 Jan 16.

Abstract

Background: The ECM (extracellular matrix) provides the microenvironmental niche sensed by resident vascular smooth muscle cells (VSMCs). Aging and disease are associated with dramatic changes in ECM composition and properties; however, their impact on VSMC phenotype remains poorly studied.

Methods: Here, we describe a novel in vitro model system that utilizes endogenous ECM to study how modifications associated with age and metabolic disease impact VSMC phenotype. ECM was synthesized using primary human VSMCs and modified during culture or after decellularization. Integrity, stiffness, and composition of the ECM was measured using superresolution microscopy, atomic force microscopy, and proteomics, respectively. VSMCs reseeded onto the modified ECM were analyzed for viability and osteogenic differentiation.

Results: ECMs produced in response to mineral stress showed extracellular vesicle-mediated hydroxyapatite deposition and sequential changes in collagen composition and ECM properties. VSMCs seeded onto the calcified ECM exhibited increased extracellular vesicle release and Runx2 (Runt-related transcription factor 2)-mediated osteogenic gene expression due to the uptake of hydroxyapatite, which led to increased reactive oxygen species and the induction of DNA damage signaling. VSMCs seeded onto the nonmineralized, senescent ECM also exhibited increased Runx2-mediated osteogenic gene expression and accelerated calcification. In contrast, glycated ECM specifically induced increased ALP (alkaline phosphatase) activity, and this was dependent on RAGE (receptor for advanced glycation end products) signaling with both ALP and RAGE receptor inhibition attenuating calcification.

Conclusions: ECM modifications associated with aging and metabolic disease can directly induce osteogenic differentiation of VSMCs via distinct mechanisms and without the need for additional stimuli. This highlights the importance of the ECM microenvironment as a key driver of phenotypic modulation acting to accelerate age-associated vascular pathologies and provides a novel model system to study the mechanisms of calcification.

Keywords: DNA damage; collagen; gene expression; hydroxyapatites; phenotype.

MeSH terms

  • Age Factors
  • Aging* / metabolism
  • Aging* / pathology
  • Cell Differentiation
  • Cells, Cultured
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Core Binding Factor Alpha 1 Subunit / metabolism
  • DNA Damage
  • Durapatite / metabolism
  • Extracellular Matrix* / metabolism
  • Extracellular Matrix* / pathology
  • Extracellular Vesicles / metabolism
  • Glycation End Products, Advanced / metabolism
  • Humans
  • Muscle, Smooth, Vascular* / metabolism
  • Muscle, Smooth, Vascular* / pathology
  • Myocytes, Smooth Muscle* / metabolism
  • Myocytes, Smooth Muscle* / pathology
  • Osteogenesis* / genetics
  • Phenotype
  • Reactive Oxygen Species / metabolism
  • Receptor for Advanced Glycation End Products / metabolism
  • Signal Transduction
  • Vascular Calcification* / genetics
  • Vascular Calcification* / metabolism
  • Vascular Calcification* / pathology

Substances

  • Core Binding Factor Alpha 1 Subunit
  • RUNX2 protein, human
  • Receptor for Advanced Glycation End Products
  • Durapatite
  • Reactive Oxygen Species
  • Glycation End Products, Advanced